Gout, genetics and ABC transporters

F1000 Biology Reports

Volumn 3, Issue 1, 2011, Pages

  Basseville, Agnès ^a   Bates, Susan E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CELL SURFACE PROTEIN; CHAPERONE; MITOXANTRONE; URIC ACID;

AGED; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FEMALE; GOUT; HUMAN; MALE; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; URIC ACID BLOOD LEVEL; WILD TYPE;

EID: 80655139687     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B3-23     Document Type: Article

References (36)

1. Brook RA, Forsythe A, Smeeding JE, Lawrence Edwards N: Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 2010, 26:2813-21.
2. Zhu Y, Pandya BJ, Choi HK: Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63:3136-41.
3. Richette P, Bardin T: Gout. Lancet 2010, 375:318-28.
4. Riches PL, Wright AF, Ralston SH: Recent insights into the pathogenesis of hyperuricaemia and gout. Hum Mol Genet 2009, 18:R177-84.
5. Choi HK, Zhu Y, Mount DB: Genetics of gout. Curr Opin Rheumatol 2010, 22:144-51. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
6. Merriman TR, Dalbeth N: The genetic basis of hyperuricaemia and gout. Joint Bone Spine 2011, 78:35-40.
7. Yang Q, Guo CY, Cupples LA, Levy D, Wilson PW, Fox CS: Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 2005, 54:1435-41. (Pubitemid 41527011)
8. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS: Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008, 372:1953-61. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
9. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, Mangino M, Albrecht E, Wallace C, Farrall M, Johansson A, Nyholt DR, Aulchenko Y, Beckmann JS, Bergmann S, Bochud M, Brown M, Campbell H; EUROSPAN Consortium, Connell J, Dominiczak A, Homuth G, Lamina C, McCarthy MI; ENGAGE Consortium, Meitinger T, Mooser V, Munroe P, Nauck M, Peden J, et al.: Metaanalysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009, 5:e1000504. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
10. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, Lai S, Dei M, Orrù M, Albai G, Bandinelli S, Schlessinger D, Lakatta E, Scuteri A, Najjar SS, Guralnik J, Naitza S, Crisponi L, Cao A, Abecasis G, Ferrucci L, Uda M, Chen WM, Nagaraja R: The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007, 3:e194.
11. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, Ahmadi K, Dobson RJ, Marcano AC, Hajat C, Burton P, Deloukas P, Brown M, Connell JM, Dominiczak A, Lathrop GM, Webster J, Farrall M, Spector T, Samani NJ, Caulfield MJ, Munroe PB: Genomewide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-49. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
12. Phay JE, Hussain HB, Moley JF: Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 2000, 66:217-20. (Pubitemid 30429757)
13. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, et al.: SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008, 40:437-42. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
14. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH: Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 2004, 279:16229-36. (Pubitemid 38509316)
15. Döring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, Fischer G, Henke K, Klopp N, Kronenberg F, Paulweber B, Pfeufer A, Rosskopf D, Völzke H, Illig T, Meitinger T, Wichmann HE, Meisinger C: SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008, 40:430-6. (Pubitemid 351454014)
16. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H: Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417:447-52. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
17. Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, Hosoya T: Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004, 15:164-73. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
18. Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE: Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006, 54:292-300. (Pubitemid 43124109)
19. Shima Y, Teruya K, Ohta H: Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006, 79:2234-7. (Pubitemid 44649204)
20. Tu HP, Chen CJ, Lee CH, Tovosia S, Ko AM, Wang SJ, Ou TT, Lin GT, Chiang SL, Chiang HC, Chen PH, Chang SJ, Lai HM, Ko YC: The SLC22A12 gene is associated with gout in Han Chinese and Solomon Islanders. Ann Rheum Dis 2010, 69:1252-4.
21. Chong SS, Kristjansson K, Zoghbi HY, Hughes MR: Molecular cloning of the cDNA encoding a human renal sodium phosphate transport protein and its assignment to chromosome 6p21.3-p23. Genomics 1993, 18:355-9. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
22. Iharada M, Miyaji T, Fujimoto T, Hiasa M, Anzai N, Omote H, Moriyama Y: Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem 2010, 285:26107-13. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
23. Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, Yamanaka M, Endou H, Kamatani N, Yamanaka H: Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis 2010, 69:1232-4. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
24. Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y: Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv Drug Deliv Rev 2009, 61:26-33.
25. Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, Russel FG, Masereeuw R: The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 2008, 73:220-5. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
26. Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M: Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 2009, 106:10338-42. F1000 Factor 12 Evaluated by Robert Robey and Susan Bates 29 Jun 2009, Fabien Sohet and Dominique Eladari 25 Jun 2009, Richard J Naftalin 25 Jun 2009
27. Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, Ito K, Kusanagi Y, Chiba T, Tadokoro S, Takada Y, Oikawa Y, Inoue H, Suzuki K, Okada R, Nishiyama J, Domoto H, Watanabe S, Fujita M, Morimoto Y, Naito M, Nishio K, Hishida A, Wakai K, Asai Y, Niwa K, Kamakura K, Nonoyama S, Sakurai Y, Hosoya T, et al.: Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009, 1:5ra11. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
28. Wang B, Miao Z, Liu S, Wang J, Zhou S, Han L, Meng D, Wang Y, Li C, Ma X: Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Genet 2010, 127:245-6. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
29. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, Merriman ME, Topless R, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Merriman TR: A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet 2010, 19:4813-9. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
30. Polgar O, Robey R, Bates S: ABCG2: structure, function and role in drug response. Expert Opin Drug Metab Toxicol 2008, 4:1-15.
31. Sissung TM, Baum CE, Kirkland CT, Gao R, Gardner ER, Figg WD: Pharmacogenetics of membrane transporters: an update on current approaches. Mol Biotechnol 2010, 44:152-67. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
32. Loo TW, Clarke DM: Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J Biol Chem 1997, 272:709-12. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
33. Grasemann H, Ratjen F: Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs 2010, 15:653-9. F1000 Factor 6 Evaluated by Susan Bates 14 Oct 2011
34. Polgar O, Ierano C, Tamaki A, Stanley B, Ward Y, Xia D, Tarasova N, Robey R, Bates S: Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. Biochemistry 2010, 49:2235-45.
35. Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH: Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 2011, 124:155-63.
36. Terkeltaub R: Gout. Novel therapies for treatment of gout and hyperuricemia. Arthritis Res Ther 2009, 11:236.